• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PXS
Click for more information
0.00% 8.5¢

PHARMAXIS LTD

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PXS
Ann: US FDA Convenes Advisory Committee for Bronchitol 		26/03/19 0 148
26/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  148 
PXS
Company Update on CDI Clinical Trial and New Strategic Focus 		19/03/19 1 4.7K
19/03/19 Last post  newB Comments Created with Sketch.  1  Views Created with Sketch.  4.7K 
PXS
Ann: Becoming a substantial holder 		05/03/19 0 210
05/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  210 
PXS
Ann: Ceasing to be a substantial holder 		04/03/19 1 562
04/03/19 Last post  newB Comments Created with Sketch.  1  Views Created with Sketch.  562 
PXS
Ann: Boehringer Completes Enrollment of Phase 2A Trial in NASH 		25/02/19 0 362
25/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  362 
PXS
Ann: Pharmaxis Commences Phase 1 LOX Clinical Trial 		22/02/19 1 678
22/02/19 Last post  Mango22 Comments Created with Sketch.  1  Views Created with Sketch.  678 
PXS
Ann: Half Yearly Report and Accounts 		15/02/19 1 543
15/02/19 Last post  newB Comments Created with Sketch.  1  Views Created with Sketch.  543 
PXS
Where’s Bakkie 		09/02/19 3 1.2K
09/02/19 Last post  newB Comments Created with Sketch.  3  Views Created with Sketch.  1.2K 

See All Discussions arrow Created with Sketch.

Top Stories

HotCopper Highlights: Your most watched stocks for Week 46, 2024

What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.